Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
140.00
+7.00
+(5.26%)
At close: February 27 at 4:00:10 PM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| J7Z.DU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 2/27/2025 |
| Downgrade | Cantor Fitzgerald: Overweight to Neutral | 2/26/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 2/26/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 2/26/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 2/26/2025 |
| Maintains | Needham: Buy to Buy | 2/26/2025 |
Related Tickers
MAGLE.ST Magle Chemoswed Holding AB (publ)
31.00
-4.32%
NV3P.F NanoViricides, Inc.
1.1800
+4.42%
C4X.F Valerio Therapeutics Société anonyme
0.0511
-0.39%
HQ1.MU Oruka Therapeutics Inc. R
10.20
-0.97%
RGO.DU Regeneron Pharmaceuticals Inc
670.80
-1.93%
MOC.WA Molecure S.A.
8.99
-0.11%
PH4.F CStone Pharmaceuticals
0.4500
+4.17%
BSSP Baseline Productions, Inc.
0.0001
0.00%
ARDX.MX Ardelyx, Inc.
105.50
0.00%
AREC.L Arecor Therapeutics plc
50.00
-2.91%